ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Sign-ups for 2019 Obamacare Insurance Fall to 8.5 Million People

Caroline Humer  |  

NEW YORK (Reuters)–The number of Americans who signed up for 2019 insurance plans created by the Affordable Care Act, often called Obamacare, fell by about 4 percent to 8.5 million people from 2018, the U.S. government said on Wednesday. Enrollment had been running about 10 percent lower but picked up during the past week, reflecting…

Maryland Judge to Weigh Obamacare Case

Sarah N. Lynch  |  

(Reuters)—Days after a judge in Texas declared that the Obamacare healthcare law is unconstitutional, Maryland’s Democratic attorney general on Wednesday will pursue his request that another judge rule the opposite way. The lawsuit brought by Maryland Attorney General Brian Frosh also seeks to challenge President Donald Trump’s appointment of Matthew Whitaker as acting attorney general,…

Mourning the Loss of NIAMS Director Stephen Katz, MD, PhD

Francis S. Collins, MD, PhD, NIH Director  |  

“It is with a profoundly heavy heart that I share with you the sad news that we have lost one of our most beloved leaders at NIH. Steve Katz, MD, PhD, the long-time director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), died early this morning after suffering a catastrophic stroke….

Bimekizumab Promising for PsA

  |  

CHICAGO—Bimekizumab is an investigational interleukin (IL) 17A and IL-17 neutralizing agent being studied to modulate inflammation in psoriasis, psoriatic arthritis and ankylosing spondylitis. During the late-breaking abstract session at the 2018 ACR/ARHP Annual Meeting, researchers reported on the results of a 48-week, Phase 2b, randomized, double-blind, placebo-controlled study of bimekizumab in patients with active psoriatic…

New Guideline for the Treatment of Psoriatic Arthritis

  |  

ACR guidelines include recommendations for the management of patients with particular conditions or diseases. Guidelines are developed using a systematic process and are based on available evidence and the clinical experience and expertise of rheumatologists and other interested stakeholders. In the January issue of Arthritis & Rheumatology, Arthritis Care & Research and the Journal of…

When Immunodeficiency & Autoimmunity Coexist

  |  

When a patient has both primary immune deficiency and autoimmune disease, the combination can lead to life-threatening complications. Here are some insights into the challenges of diagnosing and treating this rare subset of patients…